Lupus is an autoimmune disease where the immune system attacks its own tissues. It can affect many body systems like joints, skin, kidneys, lungs and brain. Symptoms vary but may include facial rashes, fatigue, fever and joint pain. There is no cure for lupus but treatments can control symptoms. Treatments include medications like hydroxychloroquine and corticosteroids to reduce inflammation and prevent flares. Managing lupus requires balancing medications, exercise, sleep and avoiding triggers like sunlight.
Lupus is a chronic autoimmune disease that occurs when a person's immune system attacks their own tissues and organs. Learn about the symptoms of lupus, how it is diagnosed and new treatment options to live well with lupus.
Systemic lupus erythematosus (SLE) is the prototypic multisystem autoimmune disorder with a broad spectrum of clinical presentations encompassing almost all organs and tissues.
The extreme heterogeneity of the disease has led some investigators to propose that SLE represents a syndrome rather than a single disease.
Lupus was first recognised as a systemic disease with visceral manifestations by Moriz Kaposi (1837–1902).
Lupus is a chronic autoimmune disease that occurs when a person's immune system attacks their own tissues and organs. Learn about the symptoms of lupus, how it is diagnosed and new treatment options to live well with lupus.
Systemic lupus erythematosus (SLE) is the prototypic multisystem autoimmune disorder with a broad spectrum of clinical presentations encompassing almost all organs and tissues.
The extreme heterogeneity of the disease has led some investigators to propose that SLE represents a syndrome rather than a single disease.
Lupus was first recognised as a systemic disease with visceral manifestations by Moriz Kaposi (1837–1902).
Systemic lupus erythematosus (lupus) is a disease of the immune system. Normally, the immune system protects the body from infection. However, in lupus, the immune system inappropriately attacks tissues in various parts of the body. This abnormal activity of the immune system leads to tissue damage and illness.To know more visit here: www.lazoi.com
SLE still an enigma where both patient and health care professionals are blind and do more harm than saving the patient. Hope in future anything can be done to save the patient from the grip of lupus,
Lupus is a systematic autoimmune disease which affects the body’s tissues and organs by your own immune system thinking that they are foreign. Lupus is a chronic inflammatory disease that affects various parts of the body including joints, skin, kidneys, blood cells, brain, heart, and lungs. Lupus is also known as systemic lupus erythematosus or SLE. The exact cause of lupus is very difficult to diagnose, although it’s a combination of genes, hormones and environmental factors. It affects women between 18 and 40 years of age.
Systemic lupus erythematosus (lupus) is a disease of the immune system. Normally, the immune system protects the body from infection. However, in lupus, the immune system inappropriately attacks tissues in various parts of the body. This abnormal activity of the immune system leads to tissue damage and illness.To know more visit here: www.lazoi.com
SLE still an enigma where both patient and health care professionals are blind and do more harm than saving the patient. Hope in future anything can be done to save the patient from the grip of lupus,
Lupus is a systematic autoimmune disease which affects the body’s tissues and organs by your own immune system thinking that they are foreign. Lupus is a chronic inflammatory disease that affects various parts of the body including joints, skin, kidneys, blood cells, brain, heart, and lungs. Lupus is also known as systemic lupus erythematosus or SLE. The exact cause of lupus is very difficult to diagnose, although it’s a combination of genes, hormones and environmental factors. It affects women between 18 and 40 years of age.
this research is made by a dental student (me) under supervision of our oral medicine specialist dr. muhassad almudhafer and this research is collected from several articles hope u like it
this my email if u would like to contact me - mnmmnz4503.mm@gmail.com
Abortion and other Causes of Early Pregnancy Bleeding.pdfChantal Settley
Describe common causes of bleeding in early pregnancy.
Describe the clinical classifications of abortion, the legal aspects of abortion in Ethiopia, and the safe methods used in health facilities.
Identify the warning signs and the emergency treatment required before referral for early pregnancy bleeding.
Describe the features of woman-friendly comprehensive post-abortion care, including the post-abortion family planning service
List the advantages of regionalised perinatal care.
Describe the functioning of a perinatal-care clinic.
Communicate better with patients and colleagues.
Safely transfer a patient to hospital.
Determine the maternal mortality rate.
Medical problems during pregnancy, labour and the puerperium.pdfChantal Settley
Diagnose and manage cystitis.
Reduce the incidence of acute pyelonephritis in pregnancy.
Diagnose and manage acute pyelonephritis in pregnancy.
Diagnose and manage anaemia during pregnancy.
Identify patients who may possibly have heart valve disease.
Manage a patient with heart valve disease during labour and the puerperium.
Manage a patient with diabetes mellitus.
Explain the wider meaning of family planning.
Give contraceptive counselling.
List the efficiency, contraindications and side effects of the various contraceptive methods.
List the important health benefits of contraception.
Advise a postpartum patient on the most appropriate method of contraception.
Define the puerperium.
List the physical changes which occur during the puerperium.
Manage the normal puerperium.
Assess a patient at the 6-week postnatal visit.
Diagnose and manage the various causes of puerperal pyrexia.
Recognise the puerperal psychiatric disorders.
Diagnose and manage secondary postpartum haemorrhage.
Teach the patient the concept of ‘the mother as a monitor’.
Uterine contractions continue, although less frequently than in the second stage.
The uterus contracts and becomes smaller and, as a result, the placenta separates.
The placenta is squeezed out of the upper uterine segment into the lower uterine segment and vagina. The placenta is then delivered.
The contraction of the uterine muscle compresses the uterine blood vessels and this prevents bleeding. Thereafter, clotting (coagulation) takes place in the uterine blood vessels due to the normal clotting mechanism.
Identify the onset of the second stage of labour.
Decide when the patient should start to bear down.
Communicate effectively with the patient during labour.
Use the maternal effort to the best advantage when the patient bears down.
Make careful observations during the second stage of labour.
Assess the fetal condition during the time the patient bears down.
Accurately evaluate progress in the second stage of labour.
Manage a patient with a prolonged second stage of labour.
Diagnose and manage impacted shoulders.
Monitoring the condition of the fetus during the first stage of labour.pdfChantal Settley
Monitor the condition of the fetus during labour.
Record the findings on the partogram.
Understand the significance of the findings.
Understand the causes and signs of fetal distress.
Interpret the significance of different fetal heart rate patterns and meconium-stained liquor.
Manage any abnormalities which are detected.
1.1 Define and use correctly all of the key terms
1.2 Describe the signs of true labour and distinguish between true and false labour
1.3 Explain to the mother how to recognise the onset of true labour
1.4 Describe the characteristic features and mechanisms of the four stages of labour
1.5 Describe the seven cardinal movements made by the baby as it descends the birth canal in a normal labour
10.2 Preterm labour and preterm rupture of the membranes.pdfChantal Settley
Define preterm labour and preterm rupture of the membranes.
Understand why these conditions are very important.
Understand the role of infection in causing preterm labour and preterm rupture of the membranes.
List which patients are at increased risk of these conditions.
Understand what preventive measures should be taken.
Diagnose preterm labour and preterm rupture of the membranes.
Manage these conditions.
Understand why an antepartum haemorrhage should always be regarded as serious.
Provide the initial management of a patient presenting with an antepartum haemorrhage.
Understand that it is sometimes necessary to deliver the fetus as soon as possible, in order to save the life of the mother or infant.
Diagnose the cause of the bleeding from the history and examination of the patient.
Correctly manage each of the causes of antepartum haemorrhage.
Diagnose the cause of a blood-stained vaginal discharge and administer appropriate treatment.
Define hypertension in pregnancy.
Give a simple classification of the hypertensive disorders of pregnancy.
Diagnose pre-eclampsia and chronic hypertension.
Explain why the hypertensive disorders of pregnancy must always be regarded as serious.
List which patients are at risk of developing pre-eclampsia.
List the complications of pre-eclampsia.
Differentiate pre-eclampsia from pre-eclampsia with severe features.
Give a practical guide to the management of pre-eclampsia.
Provide emergency management for eclampsia.
Manage gestational hypertension and chronic hypertension during pregnancy.
7.2 New Microsoft PowerPoint Presentation (2).pdfChantal Settley
Welcome the woman and ask her to sit near you and facing you.
Smile and make good eye contact with her.
Reassure her that you will always maintain her privacy and confidentiality
Without her permission, do not include a third person in the meeting.
Use simple non-medical language and terminologies throughout that she can understand, and check frequently that she has really understood.
Actively listen to her, using gestures and verbal communication to show her that you are paying attention to what she says.
Encourage her to ask questions, express her needs and concerns, and seek clarification of any information that she does not understand.
6.4 Assessment of fetal growth and condition during pregnancy.pdfChantal Settley
When you have completed this unit you should be able to:
• Assess normal fetal growth.
• List the causes of intra-uterine growth restriction.
• Understand the importance of measuring the symphysis-fundus height.
• Understand the clinical significance of fetal movements.
• Use a fetal-movement chart.
• Manage a patient with decreased fetal movements.
• Understand the value of antenatal fetal heart rate monitoring.
What possible complications to look for:
Antepartum haemorrhage
Pre-eclampsia
proteinuria and a rise in the blood pressure.
Cervical changes
Symphysis-fundus height measurement
below the 10th centile?
above the 90th centile?
To review and act on the results of the screening or special investigations done at the booking visit.
2. To perform the second assessment for risk factors.
If possible, all the results of the screening tests should be obtained at the first visit.
Assess normal fetal growth.
List the causes of intra-uterine growth restriction.
Understand the importance of measuring the symphysis-fundus height.
Understand the clinical significance of fetal movements.
Use a fetal-movement chart.
Manage a patient with decreased fetal movements.
Understand the value of antenatal fetal heart rate monitoring.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
2. What is Lupus?
• Lupus is a systemic autoimmune disease that occurs when the body's
immune system attacks its own tissues and organs.
• Inflammation caused by lupus can affect many different body systems —
including your joints, skin, kidneys, blood cells, brain, heart and lungs.
• Lupus can be difficult to diagnose because its signs and symptoms often
mimic those of other ailments. The most distinctive sign of lupus — a
facial rash that resembles the wings of a butterfly unfolding across both
cheeks — occurs in many but not all cases of lupus.
• Some people are born with a tendency toward developing lupus, which
may be triggered by infections, certain drugs or even sunlight. While
there's no cure for lupus, treatments can help control symptoms.
4. Symptoms
• No two cases of lupus are exactly alike.
• Signs and symptoms may come on suddenly or
develop slowly, may be mild or severe, and may
be temporary or permanent.
• Most people with lupus have mild disease
characterized by episodes — called flares —
when signs and symptoms get worse for a while,
then improve or even disappear completely for a
time.
5. Symptoms
• The signs and symptoms of lupus that you experience will depend on which body
systems are affected by the disease. The most common signs and symptoms include:
– Fatigue
– Fever
– Joint pain, stiffness and swelling
– Butterfly-shaped rash on the face that covers the cheeks and bridge of the nose or rashes elsewhere
on the body
– Skin lesions that appear or worsen with sun exposure (photosensitivity)
– Fingers and toes that turn white or blue when exposed to cold or during stressful periods (Raynaud's
phenomenon)
– Shortness of breath
– Chest pain
– Dry eyes
– Headaches, confusion and memory loss
– Haematological disorders like thrombocytopenia and leukopenia
– MUST AT LEAST HAVE FOUR OF THE SIGNS AND SYMTOMS BEFORE DIAGNOSIS CAN BE MADE
6. Causes
• Lupus occurs when your immune system attacks
healthy tissue in your body (autoimmune disease).
• Some potential triggers include:
– Sunlight. Exposure to the sun may bring on lupus skin
lesions or trigger an internal response in susceptible
people.
– Infections. Having an infection can initiate lupus or cause a
relapse in some people.
– Medications. Lupus can be triggered by certain types of
blood pressure medications, anti-seizure medications and
antibiotics. People who have drug-induced lupus usually
get better when they stop taking the medication. Rarely,
symptoms may persist even after the drug is stopped.
7. Risk factors
• Your sex. Lupus is more common in women.
• Age. Although lupus affects people of all ages,
it's most often diagnosed between the ages of
15 and 45.
• Race. Lupus is more common in African-
Americans, Hispanics and Asian-Americans.
8. Complications
• Kidneys. Lupus can cause serious kidney damage,
and kidney failure is one of the leading causes of
death among people with lupus.
• Brain and central nervous system. If your brain is
affected by lupus, you may experience
headaches, dizziness, behavior changes, vision
problems, and even strokes or seizures. Many
people with lupus experience memory problems
and may have difficulty expressing their thoughts.
9. Complications
• Blood and blood vessels. Lupus may lead to blood
problems, including anemia and increased risk of
bleeding or blood clotting. It can also cause
inflammation of the blood vessels (vasculitis).
• Lungs. Having lupus increases your chances of
developing an inflammation of the chest cavity lining
(pleurisy), which can make breathing painful. Bleeding
into lungs and pneumonia also are possible.
• Heart. Lupus can cause inflammation of your heart
muscle, your arteries or heart membrane (pericarditis).
The risk of cardiovascular disease and heart attacks
increases greatly as well.
10. Complications
• Infection. People with lupus are more
vulnerable to infection because both the
disease and its treatments can weaken the
immune system.
• Cancer. Having lupus appears to increase your
risk of cancer; however the risk is small.
11. Complications
• Bone tissue death (avascular necrosis). This occurs
when the blood supply to a bone diminishes, often
leading to tiny breaks in the bone and eventually to the
bone's collapse.
• Pregnancy complications. Women with lupus have an
increased risk of miscarriage. Lupus increases the risk
of high blood pressure during pregnancy
(preeclampsia) and preterm birth. To reduce the risk of
these complications, doctors often recommend
delaying pregnancy until your disease has been under
control for at least six months.
12. Management of Lupus
• There is no permanent cure for SLE.
• The goal of treatment is to relieve symptoms and
protect organs by decreasing inflammation and/or the
level of autoimmune activity in the body.
• The precise treatment is decided on an individual basis.
• Many people with mild symptoms may need no
treatment or only intermittent courses of anti-
inflammatory medications.
• Those with more serious illness involving damage to
internal organ(s) may require high doses of
corticosteroids in combination with other medications
that suppress the body's immune system.
13. Management of Lupus
• People with SLE need more rest during periods of
active disease.
• Researchers have reported that poor sleep quality was
a significant factor in developing fatigue in people with
SLE.
• These reports emphasize the importance for people
and physicians to address sleep quality and the effect
of underlying depression, lack of exercise, and self-care
coping strategies on overall health.
• During these periods, carefully prescribed exercise is
still important to maintain muscle tone and range of
motion in the joints.
14. Management of Lupus
• Corticosteroids are more potent than NSAIDs in reducing
inflammation and restoring function when the disease is
active. Corticosteroids are particularly helpful when
internal organs are affected. Corticosteroids can be given
by mouth, injected directly into the joints and other tissues,
or administered intravenously.
• Unfortunately, corticosteroids have serious side effects
when given in high doses over prolonged periods, and the
doctor will try to monitor the activity of the disease in
order to use the lowest doses that are safe. Side effects of
corticosteroids include weight gain, thinning of the bones
and skin, infection, diabetes, facial puffiness, cataracts, and
death (necrosis) of the tissues in large joints.
15. Management of Lupus
• To protect from sun sensitivity, sunscreens, sun avoidance, and sun
protection clothing are used.
• Certain types of lupus rash can respond to topical cortisone medications.
• Nonsteroidal anti-inflammatory drugs (NSAIDs) are helpful in reducing
inflammation and pain in muscles, joints, and other tissues. Examples of
NSAIDs include aspirin, ibuprofen (Motrin), naproxen (Naprosyn), and
sulindac (Clinoril).
• Since the individual response to NSAIDs varies, it is common for a doctor
to try different NSAIDs to find the most effective one with the fewest side
effects.
• The most common side effects are stomach upset, abdominal pain, ulcers,
and even ulcer bleeding. NSAIDs are usually taken with food to reduce side
effects. Sometimes, medications that prevent ulcers while taking NSAIDs,
such as misoprostol (Cytotec), are given simultaneously.
16. Management of Lupus
• Hydroxychloroquine (Plaquenil) is an antimalarial
medication found to be particularly effective for
SLE people with fatigue, skin involvement, and
joint disease.
• Consistently taking Plaquenil can prevent flare-
ups of lupus.
• Side effects are uncommon but include diarrhea,
upset stomach, and eye-pigment changes.
• Eye-pigment changes are rare but require
monitoring by an ophthalmologist (eye specialist)
during treatment with Plaquenil.
17. Management of Lupus
• Hydroxychloroquine (Plaquenil) is an antimalarial
medication found to be particularly effective for SLE people
with fatigue, skin involvement, and joint disease.
• Consistently taking Plaquenil can prevent flare-ups of lupus.
• Side effects are uncommon but include diarrhea, upset
stomach, and eye-pigment changes.
• Eye-pigment changes are rare but require monitoring by an
ophthalmologist (eye specialist) during treatment with
Plaquenil.
• For resistant skin disease, other antimalarial drugs, such as
chloroquine (Aralen) or quinacrine, are considered and can
be used in combination with hydroxychloroquine.